Skip to main content
All lobbying filings

ELEKTA, INC.

Lobbying for ELEKTA, INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $30,000.00 expenses · posted Jul 22, 2025

Official filing document

 Bills named in this filing 2
 Lobbying activity 6
Medicare/Medicaid

Medicare Reimbursement and general Medicaid issues.

Health Issues

Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031

Trade (domestic/foreign)

Trade issues between the U.S. and EU, US and China and U.S. - UK

Tariff (miscellaneous tariff bills)

Tariffs policies between US - EU, US - UK and US - China

Energy/Nuclear

Nuclear Security issues, Nuclear Health issues, Cobalt 60

Budget/Appropriations

Labor-HHS and AG-FDA appropriations bills

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem